Lion Point Capital, LP AVADEL PHARMACEUTICALS PLC Transaction History
Lion Point Capital, LP
- $37.2 Million
- Q3 2024
Number of Shares
64,000
Previous 82,500
22.42%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%